Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2349 (LINC02349)

Target
LINC02349
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Other (non-protein coding RNA)
01

Overview

LINC02349 (Long intergenic non-protein coding RNA 2349) is a non-coding RNA gene that produces an RNA transcript longer than 200 nucleotides, which does not overlap any protein-coding genes[1][3]. Genes of this class, known as lincRNAs, are distinguished by their intergenic position and lack of protein-coding potential[3][7]. LincRNAs, including LINC02349, are known to participate in the regulation of chromatin states, gene transcription, and genome architecture, and may influence cell phenotype and disease through these mechanisms, although the direct molecular and functional characterization of LINC02349 is currently lacking in the published literature[1][3][7]. LincRNAs are broadly implicated in gene expression fine-tuning and exhibit tissue specificity[3]. While lincRNAs have been associated with cancer and other pathologies, there is no direct evidence for LINC02349’s role in specific diseases or as a druggable target.

Other names
LINC02349long intergenic non-protein coding RNA 2349
02

Biological functions

Chromatin remodelingGenome architecture regulationRNA stabilizationTranscription regulationPossible enhancer-associated activity
03

Disease associations

Cancer (many lincRNAs have been implicated in cancerous processes, but LINC02349 specifically lacks direct disease-association studies as of now)Other (potential role in gene expression regulation affecting disease pathways; not specifically established for LINC02349)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2349 (LINC02349).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2349 (LINC02349).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call